A group of Chinese researchers working out of Zhejiang University have developed a high-tech insulin system that is designed to be able to make use of nanoparticle technology in order to adjust the release of insulin system, effectively helping to reduce the risk of both low and high blood glucose that can occur as the result of too much or too little insulin administration.
This insulin system makes use of biologically compatible nanoparticles whose surfaces are modified in order to be able to carry positive charges. This makes it possible for insulin molecules, which are negatively charged, to bind to the lipid nanoparticles. As a result, when blood glucose is at normal levels, insulin ends up being released slowly. However, when blood glucose level is dangerously high, the nanoparticle surface charge gets reduced, resulting in increase release of insulin.
Ultimately, this insulin system could revolutionize the lives of Type 1 diabetes patients, who currently face the burden of having to regularly utilize insulin to keep tabs on their blood glucose levels.
Self-Adjusting Insulin Systems
This System Helps Keep Blood Glucose At Desirable Levels
Trend Themes
1. Nanoparticle Insulin Systems - There is an opportunity to develop new nanoparticle-based insulin systems that can adjust insulin release based on blood glucose levels.
2. Self-regulating Insulin Systems - Self-regulating insulin systems with nanoparticles can help keep blood glucose levels within a desirable range, offering new opportunities in diabetes care.
3. Personalized Insulin Therapy - Personalized insulin therapy using nanoparticle technology and glucose monitoring can help to optimize insulin delivery for diabetes patients.
Industry Implications
1. Pharmaceuticals - Pharmaceutical companies can explore the use of nanoparticle technology for insulin delivery, enabling more effective insulin therapy for diabetes patients.
2. Biotechnology - Biotech companies can develop personalized insulin therapy using nanoparticle technology to adjust insulin release based on individual glucose levels.
3. Healthcare Technology - Healthcare technology companies can create new wearable devices that use nanoparticle-based insulin delivery systems to monitor blood glucose levels in real time.